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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2005.04.019Objective: Mitral regurgitation is a complication for many patients with congestive
heart failure. Although this regurgitation is considered purely functional, we hy-
pothesize that the alterations in cardiac geometry and function induce dysfunctional
remodeling of the mitral valve, which can be demonstrated by alterations in the
material behavior of the leaflets and chordae.
Methods: Mitral leaflets and chordae from 23 valves from transplant recipient hearts
(11 with dilated and 12 with ischemic cardiomyopathy) and from 21 normal valves
(from autopsy) were mechanically tested.
Results: Radially oriented anterior mitral leaflet strips from failing hearts were 61%
stiffer and 23% less viscous on average than those from autopsy control hearts. The
mean stiffness of circumferentially oriented anterior leaflet strips was 50% higher
than that of control hearts. Leaflet extensibility was reduced 35% overall. Likewise,
the failing heart chordae were an average of 16% stiffer (all P  .05).
Conclusions: Mitral valves in congestive heart failure have significantly altered
mechanics that suggest that the tissue is permanently distended and fibrotic and
might be unable to stretch sufficiently to cover the valve orifice. These material
changes in the valve tissues accompany the biochemical alterations in extracellular
matrix composition that we have previously reported. Our finding of leaflet and
chordal remodeling suggests that mitral regurgitation in patients experiencing heart
failure might not be purely functional and that these mitral valves should not be
considered normal. Moreover, there are implications for strategies of mitral valve
surgery or percutaneous approaches in this patient population.
Mitral valve dysfunction occurs in 55% to 75% of patients with congestiveheart failure (CHF) presenting as ischemic or idiopathic dilated cardio-myopathy.1-4 The prognosis is poor for all patients with CHF but is
especially poor for patients with mitral regurgitation (MR), who have significantly
more complications1,3 and survival 2-fold1,5 to 10-fold3 lower than that of patients
without MR. Survival of patients with even mild MR is only half that of patients
with no MR.1 The occurrence of MR in these patients has long been perceived to be
primarily a functional consequence of the altered cardiac geometry.6,7 The expla-
nation is that there is nothing wrong with the valve itself but that it is being distorted
by the dilatation of the ventricles, the valve annulus, or both. This interpretation has
largely been based on observations that the mitral valves appear qualitatively normal
on echocardiographic and gross morphologic examinations. In animal models,
however, sustained alteration of the normal valvular loading patterns was shown to
affect the valvular microstructure,8-10 resulting in regurgitation that might have been
partly organic, as opposed to purely functional. On the basis of these previous
studies, our hypothesis is that the alterations in cardiac geometry and function found
in CHF will disturb the normal mitral valve loading and consequently induce
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CDdysfunctional remodeling of the valve. Although our hy-
pothesis is but one possible interpretation, we believe that
such remodeling changes in valvular microstructure and
extracellular matrix composition would be indirectly dem-
onstrated by abnormal material behavior of the valve leaf-
lets and chordae. Therefore, this study investigated the
possibility for valvular dysfunctional remodeling by mea-
suring the material properties of mitral valves from the
explanted hearts of transplant recipients.
Methods
Subjects
Mitral valves were obtained from the recipient hearts of 23 patients
undergoing heart transplantation (Table 1). The use of these tissues
was approved by the institutional review board. These patients
were previously given diagnoses of CHF on the basis of severe left
ventricular systolic dysfunction and either severe left ventricular
dilatation or a history of atherosclerosis, coronary artery disease,
or myocardial infarction. Ischemic cardiomyopathy (ICM; n 12)
was distinguished from dilated cardiomyopathy (DCM; n 11) on
the basis of the presence of segmental wall motion abnormalities
and significant obstructive coronary disease. Other than these
distinguishing characteristics, there were no significant differences
in cardiac geometry or functional parameters between subjects
with ICM and subjects with DCM. All patients demonstrated
typical characteristics of CHF,5 with a mean MR severity of 2.4 
1.0 (Table 2). Patients who had mitral valve surgery before trans-
plantation were excluded from the study. Normal control mitral
valves were obtained from autopsy from 21 persons who died of
causes other than cardiovascular or cardiac disease. The autopsy
control specimens were selected according to the least time be-
TABLE 1. Subject characteristics
Group Subjects Sex, F/M Age, y*
Control specimens 21 7/14 48 18
Transplant specimens 23 7/16 50 15
Dilated 11 5/6 49 15
Ischemic 12 2/10 51 16
*Mean  standard deviation.
TABLE 2. Cardiac chamber dimensions and functional par
Measurement Subjects
MV annular diameter (4C), cm 9
LVISD, cm 10
LVIDD, cm 10
IVS thickness, cm 10
PW thickness, cm 10
LA diameter, cm 10
MR, grade 0-4 10
Ejection fraction, % 10
Data are presented as means standard deviation. DCM, Dilated cardiomy
left ventricular internal systolic diameter, LVIDD, left ventricular internal di
MR, mitral regurgitation.
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between the harvesting of valves from the control and transplant
groups. There were no significant differences in age between the
CHF and control groups.
Specimen Preparation
The transplant recipient hearts were obtained immediately after
transplantation and pathologic inspection. The mitral valve was
dissected from the heart and stored in fresh Hanks balanced saline
solution at 4°C for up to 5 days before testing. Our laboratory has
previously determined that valves kept at 4°C retain their mechan-
ical properties for up to 5 days.11 This finding also justifies our use
of autopsy valves, which were harvested less than 24 hours post-
mortem from cadavers kept in cold storage (4°C) as suitable and
valid control specimens for the transplant valves.
All chordae longer than 10 mm were cut from the leaflet for
testing. After removing the remainder of the chordae, the leaflets
were cut into strips (10  14 mm) oriented circumferentially or
radially (parallel or orthogonal to the annular edge, respectively;
Figure 1). Test specimens were noted as originating from either the
posterior or anterior leaflet, and chordal insertions were character-
ized as marginal or basal. Several specimens were available from
each valve (Table 3). It was not possible to obtain a circumferential
and a radial sample from the same anterior leaflet. Only about half
of the posterior leaflets had suitable tissue area to cut circumfer-
ential specimens. In addition, a small percentage of the valves
(both transplant and control valves) were missing either the ante-
rior or posterior leaflet because they were either retained by the
pathologists or damaged during the ventricular transection. Fi-
nally, none of the control valves (unlike the transplant valves) had
posterior leaflets large enough to cut radially oriented strips, and
therefore differences in radial material properties of the posterior
leaflets could not be tested.
Mechanical Testing
Mechanical testing was performed as previously described by
Barber and colleagues.12,13 Briefly, leaflet strip thickness was
measured with a digital indicator (Mitutoyo, Tokyo, Japan) and
used to calculate the leaflet cross-sectional area. The average
chordal cross-sectional area was calculated from their weight,
length, and assumed density of 1.01 g/mL (on the basis of their
buoyancy in Hanks saline) measured after testing.13 Specimens
ters
DCM Subjects ICM
4.90 0.40 11 4.59  0.56
6.50 1.21 10 6.14  1.18
7.22 1.19 10 6.91  1.03
0.93 0.19 10 0.93  0.28
1.08 0.29 10 0.93  0.20
4.65 0.78 11 5.05  0.59
2.15 1.16 11 2.55  0.91
18.0 5.21 12 21.1  8.75
y; ICM, ischemic cardiomyopathy; MV, mitral valve; 4C, 4-chamber; LVISD,
c diameter; IVS, intraventricular septum; PW, posterior wall; LA, left atrial;ame
opath
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(Model 8511; Instron, Canton, Mass). During testing, specimens
were immersed in Hanks saline (37°C). Tissue was preconditioned
until the load-displacement curves were repeatable (approximately
10 cycles). Immediately after preconditioning, one load-elongation
cycle was recorded. After a stress-relaxation test (100 seconds)
was performed to assess viscoelasticity, the specimens were
Figure 1. Mitral valves removed from heart transplant recipients
(lower) show gross similarity to normal mitral valves obtained
from autopsies (upper). The circumferential and radial directions
of the valve are also indicated.stretched to failure.
The Journal of ThoraciData and Statistical Analysis
All data were examined in customized Mathematica programs
(Wolfram Research, Champaign, Ill) to obtain stiffness, extensi-
bility, stress relaxation, and failure parameters, as described pre-
viously.12,13 Stiffness was the slope of the elongation curve, ex-
pressed both as elastic modulus (kiloPascals; normalized to
measured tissue cross-sectional area) and as tension (Newtons per
meter; normalized to idealized tissue width of leaflet strips [10
mm] or chordae [1 mm]). Extensibility was determined as the
tissue strain before the collagen fibers became fully uncrimped and
the tissue stiffened. The slope of the stress-relaxation curve (load
vs log time) was calculated to measure tissue viscosity.
Descriptive summary statistics are presented as means and
standard deviations. Group comparisons of patient characteristics
were made by using the 2 and Wilcoxon rank sum tests. Repeat-
ed-measures analyses were performed (SAS PROC MIXED; SAS
Institute, Inc, Cary, NC) to account for the lack of independence
from multiple specimens evaluated from the same valve. Univar-
iate models were initially formed to test group differences (ICM,
DCM, and control) within leaflet and chordal subgroups. Thereaf-
ter, multivariable mixed models were developed for overall leaflet
and chordae groups to evaluate group effects and interactions
while adjusting for confounders (diagnosis, leaflet origin, chordal
insertion, and test strip orientation). Within the CHF group, patient
characteristics of age, sex, diabetes, extent of CAD, and choles-
terol, as well as heart weight, posterior wall thickness, and grade
of MR, were also considered for a propensity analysis. Adjusted P
values have been provided. All statistical testing was 2-tailed, with
a significance level of .05, and was performed with SAS version
8.2 (Cary, NC).
Results
Propensity Analysis
The 2 CHF groups (ICM and DCM) did not differ with
respect to any of the explanatory factors that were consid-
ered, and there was little predictive value from the multi-
variable model. Therefore, propensity adjustments were not
included in further mixed-model analyses that are presented
here. Among all CHF valves, however, advanced age (P 
.009) and diabetes (P  .02) were related to increased
leaflet thickness. Posterior wall thickness had an inverse
association with leaflet thickness (P  .007) and a positive
association with elastic modulus (P  .04).
Physical Properties
Leaflet strips cut from the CHF valves were thinner than
control anterior and posterior leaflets (Tables 3 and 4).
Anterior leaflet strips from patients with DCM were thinnest
(P .02), with a mean thickness 10% less than that for ICM
anterior leaflets. Likewise, chordae from the CHF hearts
also had slightly smaller cross-sectional areas than normal
control chordae (P  .08, Table 3).
Material Properties
Radially and circumferentially oriented anterior leaflet
strips from CHF hearts were significantly stiffer (stiffness
c and Cardiovascular Surgery ● Volume 130, Number 3 785
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Anterior leaflet Posterior leaflet:
Circumferential ChordaeCircumferential Radial
No. of specimens (no. of valves)
Control 13 (10) 19 (11) 13 (11) 82 (13)
All transplants 12 (10) 15 (10) 14 (11) 124 (21)
Dilated 7 (6) 7 (5) 6 (4) 56 (9)
Ischemic 5 (4) 8 (5) 8 (7) 68 (12)
Thickness, mm (cross-sectional area for chordae, mm2)
Control 2.15 1.14 1.80 0.38 1.77 0.39 3.16  3.12
All transplants 1.39 0.36 1.33 0.37* 1.57 0.49 1.70  1.76
Dilated 1.32 0.28 1.28 0.49 1.57 0.45 1.39  1.24
Ischemic 1.49 0.47 1.37 0.25 1.56 0.55 2.24  2.29
Extensibility, % strain
Control 23.7 15.5 22.5 9.6 38.4 14.7 12.3  8.8
All transplants 16.8 9.1 16.0 10.7 30.9 15.0 9.7  8.8
Dilated 16.0 10.3 14.7 5.9 33.0 14.1 9.1  10.5
Ischemic 18.0 8.1 17.2 14.0 29.3 16.4 10.1  7.3
Stiffness, N/m (N/mm for chordae)
Control 6070 2140 3840 907 5510 1460 52.3  14.7
All transplants 9090 2280* 6170 1620* 6250 1910 60.8  27.9*
Dilated 9010 1700 7100 1780 5760 1370 58.8  16.7
Ischemic 9200 3160 5360 958 6630 2250 62.4  3.46
Elastic modulus, kPa (MPa for chordae)
Control 3550 2050 2292 827 3390 1660 67.4  116.9
All transplants 7150 3360* 5031 1918* 4340 1900 80.4  73.1
Dilated 7210 2530 6092 1941 3930 1560 85.6  72.2
Ischemic 7060 4640 4103 1422 4640 2160 72.3  74.9
Relaxation slope, N/(m log [time])
Control 11.87 3.54 12.53 3.01 10.19 2.46 7.16  3.19
All transplants 10.32 2.95 9.70 2.61* 11.18 1.97 6.63  2.36
Dilated 10.44 3.24 10.15 2.99 10.97 1.38 7.25  2.81
Ischemic 10.15 2.86 9.32 2.37 11.34 2.4 6.26  1.99
Failure strain, % strain
Control 39.3 18.7 56.5 19.2 60.4 17.1 32.3  12.3
All transplants 36.8 11.6 42.5 23.4 53.9 15.7 31.8  13.2
Dilated 39.2 13.8 40.4 16.1 55.2 9.2 32.3  15.4
Ischemic 33.3 7.8 44.3 29.5 52.9 19.4 31.5  11.3
Failure load, g
Control 1550 795 1090 697 741 252 1320  781
All transplants 1880 900 1240 441 823 379 1420  822
Dilated 1785 739 1430 499 704 367 1318  820
Ischemic 2010 1170 1040 290 913 386 1510  818
Failure tension, N/m (N/mm for chordae)
Control 1520 780 1070 684 727 248 12.94  7.67
All transplants 1840 883 1210 433 808 372 13.96  8.06
Dilated 1751 725 1404 490 691 360 12.93  8.05
Ischemic 1970 115 1023 285 896 379 14.81  8.03
Failure stress, kPa (MPa for chordae)
Control 881 592 661 402 450 278 14.4  26.7
All transplants 1400 798 978 419 541 271 17.2  16.4
Dilated 1380 634 1170 464 449 186 17.4  15.5
Ischemic 1430 1070 791 303 609 315 16.9  17.9Data are presented as means  standard deviation. *P  .05, congestive heart failure combined versus autopsy control.
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leaflets (Figure 2 and Tables 3 and 4). In the ICM diagnosis
group, the leaflets were also less viscous (P  .02) than
control leaflets. CHF leaflets required slightly less strain to
failure, although this was not statistically significant either
as a combined group (P  .08) or as subgroups (P  .15,
ICM; P  .17, DCM; Table 4). Extensibility was lower in
CHF hearts than in control hearts (P  .05, ICM; P  .04,
DCM) for each leaflet test strip orientation analyzed. The
leaflets from patients with DCM seemed affected the most,
although there were no statistical differences found between
the CHF groups; compared with the patients with ICM, the
mean anterior radial stiffness was 32% higher, the mean
radial elastic modulus was 48% higher, and the mean radial
failure stress was 47% higher for the patients with DCM.
As found in leaflets, the mitral valve chordae from trans-
plant hearts were slightly less extensible and more stiff (P
.05) than that chordae from autopsy control hearts (Figure 2
and Table 3). In particular, the mean stiffness of basal
chordae from transplant hearts was 17% higher than that
from normal hearts (P .02). Although the elastic modulus,
like the stiffness, was higher for the CHF chordae than for
control chordae, the wide variation in the chordal cross-
sectional area prevented the modulus difference from reach-
TABLE 4. Continued
Failure load
Effect Estimate Standard error P value
Intercept 652 145 .0001
Dx- ICM 173 186 .36
Dx- DCM 210 184 .26
Anterior leaflet 992 173 .0001
Radial 603 171 .0010
Failure tension
Effect Estimate Standard error P value
Intercept 639 142 .0001
Dx- ICM 170 183 .36
Dx- DCM 206 181 .26
Anterior leaflet 973 169 .0001
Radial 593 167 .0010
Failure stress
Effect Estimate Standard error P value
Intercept 310 119 .013
Dx- ICM 251 151 .10
Dx- DCM 375 149 .016
Anterior leaflet 708 138 .0001
Radial 384 138 .008
Effects are ischemic cardiomyopathy (ICM) and dilated cardiomyopathy
(DCM) versus control, anterior versus posterior, and radial versus circum-
ferential. Dx, Diagnosis.TABLE 4. Mixed model effects for physical and mechani-
cal leaflet properties
Thickness
Effect Estimate Standard error P value
Intercept 1.938 0.151 .0001
Dx- ICM 0.399 0.220 .08
Dx- DCM 0.542 0.220 .02
Anterior leaflet 0.118 0.139 .40
Radial 0.033 0.152 .82
Extensibility
Effect Estimate Standard error P value
Intercept 38.420 2.891 .0001
Dx- ICM 7.759 3.869 .05
Dx- DCM 8.180 3.890 .04
Anterior leaflet 15.215 3.253 .0001
Radial 0.253 3.315 .94
Stiffness
Effect Estimate Standard error P value
Intercept 4730 412 .0001
Dx- ICM 1960 522 .0006
Dx- DCM 2390 525 .0001
Anterior leaflet 1840 491 .0005
Radial 2720 483 .0001
Elastic modulus
Effect Estimate Standard error P value
Intercept 2470 506 .0001
Dx- ICM 2190 641 .0016
Dx- DCM 2990 645 .0001
Anterior leaflet 1760 584 .005
Radial 1940 585 .002
Relaxation slope
Effect Estimate Standard error P value
Intercept 10.419 0.555 .0001
Dx- ICM
& anterior 2.548 1.009 .016
Dx- DCM
& anterior 1.803 0.997 .07
Anterior leaflet 1.613 0.854 .07
Radial 0.493 0.781 .53
Failure strain
Effect Estimate Standard error P value
Intercept 61.200 4.313 .0001
Dx- ICM 7.972 5.500 .15
Dx- DCM 7.705 5.527 .17
Anterior leaflet 20.074 5.102 .0003
Radial 13.814 5.046 .0090ing statistical significance. There was also no difference in
c and Cardiovascular Surgery ● Volume 130, Number 3 787
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groups. The differential diagnoses of CHF (ICM and DCM)
demonstrated similar chordal mechanics.
Discussion
This study demonstrates that mitral valves from patients
with CHF (whether ICM or DCM) had significantly altered
material properties compared with those from a control
group with the same mean age. These valves were stiffer,
less extensible, and less viscous, which we believe is due to
a dysfunctional remodeling response to the altered valvular
loading patterns in CHF. To our knowledge, this is the first
report of altered mechanics in these valves for 2 reasons.
First, the MR often found in these patients is largely pre-
sumed to be functional, as opposed to organic.6 Second,
these heart valves have been used as normal control valves
for studies of valve biology or other valve diseases. The
altered mechanics reported here contradict both of these
assumptions. Furthermore, these changes appear to repre-
Figure 2. A, Illustration of the material properties calc
text. B, Representative load-strain curves from radially
tative stress-relaxation curves from radially oriented
chordae. B through D contain specimen curves most csent a fibrotic remodeling response that has some notable
788 The Journal of Thoracic and Cardiovascular Surgery ● Septdifferences from the remodeling found in myxomatous12,13
or rheumatic valve disease.
There are likely both biochemical matrix remodeling and
geometric causes for these material property changes in the
CHF mitral valves. We recently reported that these valves
have greater concentrations of collagen (15% higher) and
cells (78% higher) and a 7% lower concentration of water.14
We propose that the greater concentration of cells indicates
an upregulation of mitogenic activity, which could be ac-
companied by increased matrix synthesis. Because collag-
ens are largely responsible for providing tissue with the
strength to withstand high tensile loads,15,16 the accumula-
tion of collagen in mitral valves would increase stiffness.
The loss of water, which is a major component of the
extracellular matrix and contributes to tissue viscoelasticity,
is likely responsible for the reduced viscous relaxation. The
reduced extensibility, on the other hand, suggests that the
leaflet and chordal tissue has also become permanently
distended and stretched. A permanent stretch of the valve
d from the load-deformation data, as explained in the
circumferentially oriented leaflet strips. C, Represen-
et strips. D, Representative load-strain curves from
y matching the average material properties of Table 4.ulate
and
leafl
loseltissues would effectively reduce the amount of tissue defor-
ember 2005
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crimped and begin to bear loads. Correspondingly, the al-
tered material load-strain curves of the valve tissues show a
leftward shift of the “crimped to uncrimped” transition
region and a higher slope of the collagenous region (Figure
2). This material change is also not due to aging alone; valve
stiffening17 and thickening18 are associated with aging, but
our group of CHF valve test specimens was found to be
thinner and yet stiffer than control specimens from the same
age group.
These findings provide support for the theory that heart
valves are not passive structures but are instead active
tissues containing cells that adapt to loading or geometry
outside of their normal range by remodeling the microstruc-
tural makeup of the tissue.8,9 Although this is only one
possible interpretation of our data, we assert that the fibrotic
change found in this study provides evidence for remodel-
ing. Reports from clinical studies,14 animal models,8-10 and
computer models19 provide additional support by showing
that mitral valves exposed to chronic, acute, or simulated
ventricular insults demonstrate upregulated DNA and col-
lagen synthesis, as well as increased cell, collagen, and
glycosaminoglycan concentrations and increased leaflet
stresses. The resulting remodeled valves, however, might
not be able to function normally in the long term.
These material property changes indicate that MR in
patients with CHF might be partly organic in nature and
might have serious clinical consequences. Our proposed
mechanism for this MR is that because of the increased
tissue stiffness, the valve cannot distend sufficiently in the
radial direction to cover the valve orifice. This mechanism
is consistent with a previous finite element model8 in which
increased stiffness and reduced extensibility caused in-
creased valve stresses and reduced coaptation, leading to
MR. Although normal mitral valves have an inherent natu-
ral redundancy of leaflet size that enables some reduction of
the coaptation region without valve leakage,8 in the setting
of CHF, an enlarged valve annulus will compound the
inability of the valve to stretch sufficiently. Furthermore,
these abnormal material properties might also affect the
valvular closing velocities and response to dP/dt. Thus
mitral valve remodeling should be incorporated into the
listing of potential causes of MR.6 The progressive cycle of
abnormal valvular loading, regurgitation, and remodeling is
likely a factor in the adverse patient prognoses that accom-
pany MR1,3,5 and might have implications for the surgical or
percutaneous approaches to manage this patient population.
Annuloplasty techniques and even edge-to-edge repair have
demonstrated a high return of 3 or 4MR in patients with
ischemic MR.20,21 Percutaneous approaches to treat this
type of MR will be challenging, and chord-sparing mitral
valve replacement might be required more often for surgi-
cally treated patients.22
The Journal of ThoraciThese findings of material property abnormalities in mi-
tral valves from failing hearts also affect more basic science
studies of heart valve disease. Although these valves were
considered normal in such studies, their material properties,
matrix, and cells are those of a remodeled tissue. Data
resulting from their use should be interpreted in light of the
valve origins.
This study had a number of limitations. One limitation
was that due to the minimum specimen size requirements
for mechanical testing, the smaller lateral scallops of the
posterior leaflet could not be tested. In particular, P3, the
leaflet region most likely affected by an ischemic event
causing displacement of the papillary muscles,23 was not
tested. Most of the posterior leaflet specimens were taken
from P2, the larger central scallop. Another limitation is that
we cannot delineate the relative contributions of functional
and organic MR to the total MR of the patients. This goal
will likely require significant animal and computer model-
ing studies. Finally, we were limited by the amount of
patient information available on the control specimens to
use in further risk-adjusted analyses.
In conclusion, we have provided the first evidence that
chronic dysfunction of the heart, geometric distortion of the
heart, or both, affects the material behavior of the mitral
valve. These material property changes would consequently
impair valve function and might worsen any existing func-
tional MR. Thus, the diagnosis of functional MR, which
characterizes the valve as a solely passive structure, might
not accurately depict the valve dysfunction in patients with
CHF.
We thank the cardiac transplantation teams, the surgical pa-
thologists, the members of the Moravec laboratory, and Songhua
Lin for her biostatistical contributions.
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